Clinical Trial Update: PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

View source ↗

Summary

Phase 2 trial of PROCHYMAL (human adult stem cells) for moderate to severe chronic obstructive pulmonary disease has completed, evaluating safety and potential …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• PROCHYMAL (allogeneic mesenchymal stem cells)

Snippet

Sponsor: Mesoblast, Inc. | Conditions: Pulmonary Disease, Chronic Obstructive, Pulmonary Emphysema | Phase 2 | Status: COMPLETED